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As the biopharmaceutical industry reduces the risk of potential contaminations by adventitious agents and 
increases process yields, high performance cell culture processes have been developed that rely on animal-free 
peptide-free, protein-free chemically defined and lipid-free media. These processes rely on cell lines that have 
been adapted to these lipid-free production conditions and have developed very effective lipid production 
capacities. These lipid-production capacities result in new challenges in the harvest and purification steps such 
as filterability, ability to clean resins and resin reuse. This oral presentation will show case how lipidomics can 
provide insights and opportunities to control the interactions between high performance bioreactor production 
processes, harvest conditions and purification. Results obtained across large scale production processes of 
three different monoclonal antibodies will be displayed. The importance of controlling lipid biosynthesis and the 
presence of lipids in the cell culture fluid prior to affinity capture chromatography will be discussed. Three 
different control strategies will be showcased and their pros and cons in terms of process yields, robustness of 
the harvest and impact on the purification process post-harvest explained. 
 
 
